P1038: TL-895, A FIRST-IN-CLASS, COVALENT BRUTON TYROSINE KINASE INHIBITOR (BTKI) FOR THE TREATMENT OF MYELOFIBROSIS (MF) PATIENTS (PTS) WITH SEVERE THROMBOCYTOPENIA (PLATELETS (PLTS) <50 K/UL)

Bibliographic Details
Main Authors:	Michael Loschi, Laszlo Rejto, Hun Chuah, Marianna Caramella, Jesus Hernández Rivas, Paolo Sportoletti, Viviane Dubruille, Marcelo Bellesso, Stefanie Gröpper, Carl Crodel, Hope Qamoos, Ashley Socotch, Zhuying Huang, Sarah Wall, Jesse Mcgreivy, Wayne P. Rothbaum, Srdan Verstovsek, Francesca Palandri
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000971048.09624.cd

Internet